Your browser doesn't support javascript.
loading
Knockdown of INPP5K compromises the differentiation of N2A cells.
Manzolillo, Annamaria; Gresing, Lennart; Hübner, Christian A; Franzka, Patricia.
Afiliação
  • Manzolillo A; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Gresing L; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Hübner CA; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Franzka P; Center of Rare Diseases, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Front Mol Neurosci ; 17: 1356343, 2024.
Article em En | MEDLINE | ID: mdl-38559586
ABSTRACT
Inositol polyphosphate 5-phosphatase K (INPP5K), also known as SKIP (skeletal muscle and kidney-enriched inositol phosphatase), is a cytoplasmic enzyme with 5-phosphatase activity toward phosphoinositides (PIs). Mutations in INPP5K are associated with autosomal recessive congenital muscular dystrophy with cataracts and intellectual disability (MDCCAID). Notably, muscular dystrophy is characterized by the hypoglycosylation of dystroglycan. Thus, far, the underlying mechanisms are only partially understood. In this study, we show that INPP5K expression increases during brain development. Knockdown of INPP5K in the neuroblastoma-derived cell line N2A impaired their neuronal-like differentiation and interfered with protein glycosylation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article